Aurobindo Pharma has informed that the Hon’ble Chief Minister of Andhra Pradesh is inaugurating the green-field manufacturing Unit located at Plot numbers 1 and 2, APIIC Industrial Park, Parawada, Phase III, Tadi Village, Parawada Mandal, Vishakhapatnam, Andhra Pradesh - 531021 of Eugia Steriles, a 100% subsidiary of Eugia Pharma Specialities and a step-down subsidiary of the Company, today on October 16, 2023. This Unit will manufacture general injectables and expected to supply globally in phases. The project cost of the Unit is approx. Rs 600 crores and the commercial production will be commenced during Q4 of FY24 in phases and subject to receipt of the necessary regulatory approvals from India as well as USA and the same will be disclosed in due course from time to time.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: